Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by CreativeOne Wealth LLC

CreativeOne Wealth LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,655 shares of the medical equipment provider’s stock after purchasing an additional 372 shares during the quarter. CreativeOne Wealth LLC’s holdings in Intuitive Surgical were worth $1,304,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in ISRG. Hazlett Burt & Watson Inc. grew its holdings in shares of Intuitive Surgical by 5.8% during the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares in the last quarter. Mitchell Mcleod Pugh & Williams Inc. grew its holdings in shares of Intuitive Surgical by 4.1% during the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after buying an additional 20 shares in the last quarter. Ullmann Wealth Partners Group LLC grew its holdings in shares of Intuitive Surgical by 1.6% during the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after buying an additional 21 shares in the last quarter. Meeder Advisory Services Inc. grew its holdings in shares of Intuitive Surgical by 0.3% during the third quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock worth $3,629,000 after buying an additional 22 shares in the last quarter. Finally, One Wealth Management Investment & Advisory Services LLC grew its holdings in shares of Intuitive Surgical by 3.4% during the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after buying an additional 23 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.6 %

NASDAQ ISRG opened at $542.00 on Friday. The company’s fifty day simple moving average is $510.03 and its 200-day simple moving average is $468.41. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $552.00. The stock has a market cap of $193.05 billion, a P/E ratio of 87.14, a PEG ratio of 5.30 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. On average, research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,459 shares of company stock valued at $26,080,251. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Royal Bank of Canada lifted their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Leerink Partners raised their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Finally, Robert W. Baird raised their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $526.06.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.